Study Looking at the Interactions Between Levels of Danuglipron and Ervogastat in the Body. A Phase 1, Open-Label Study to Evaluate the Pharmacokinetic Interactions Between PF-06882961 [Danuglipron] and PF-06865571 [Ervogastat] in Healthy Adult Participants (Part A) and Overweight Adults or Adults with Obesity Who are Otherwise Healthy (Part B).